FMP
Artivion, Inc.
AORT
NYSE
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
24.12 USD
0.7 (2.9%)
2024
2023
2022
2021
22.24M
18.82M
-5.15M
-2.58M
-13.36M
-30.69M
-19.19M
-14.83M
24.2M
23.08M
22.44M
23.98M
-1.51M
-1.39M
-1.72M
-4.47M
14.24M
14.42M
12.34M
10.71M
0
-16.19M
-25.94M
-33.23M
-15.39M
-4.05M
-13.34M
-11.56M
4.43M
-14.36M
-8.4M
-18.38M
9.5M
1.68M
-1.96M
-1.89M
0
535k
-2.23M
-1.4M
-1.34M
29.59M
6.91M
15.26M
-28.19M
-502k
-10.71M
5.66M
-11.19M
-7.43M
-10.71M
-13.09M
0
0
0
0
0
0
0
0
0
0
0
19M
-17M
6.93M
-1.7M
-249k
2.2M
865k
-1.64M
-12.22M
-358k
-1.75M
-2.75M
-3.08M
0
0
0
0
0
-559k
-1.79M
-1.91M
0
0
0
0
2.56M
4.2M
-459k
-7.22M
11.05M
11.39M
-15.87M
-15.68M
22.24M
18.82M
-5.15M
-2.58M
-11.19M
-7.43M
-10.71M
-13.09M
58.94M
39.35M
55.01M
61.96M
53.46M
58.94M
39.35M
55.01M
-5.48M
19.59M
-15.66M
-6.95M
2024
2023
2022
2021
-47.91M
-17.22M
1.98M
20.02M
-13.36M
-30.69M
-19.19M
-14.83M
0
-559k
-1.79M
-1.91M
0
0
0
0
-61.27M
-47.91M
-17.22M
1.98M
-13.36M
-31.25M
-20.99M
-19.96M
2024
2023
2022
2021
76.13M
82.18M
80.53M
83.23M
24.2M
23.08M
22.44M
23.98M
-11.19M
-7.43M
-10.71M
-13.09M
63.11M
66.53M
68.81M
72.35M
2024
2023
2022
2021
-6.38M
3.71M
-6.37M
-10.06M
247.34M
243.63M
250M
260.06M
240.96M
247.34M
243.63M
250M
All figures are in USD.